Natural Alternatives International Inc.
NAIIStock
$2.26−33.53%52W
Market Cap$14.37M
P/E—
Div yield—
Beta0.38
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-51.95%
Price vs S&P 500 (4W)-10.20%
VGM Score57.65
Market Capitalization$14.37M
Industry Peers — Pharmaceutical Preparations(21)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NAIINatural Alternatives International Inc. | A | C | D | $2.26 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $44.10 |
| RGCRegencell Bioscience Holdings Limited Ordinary Shares | — | — | F | $4.78 |
| TRLVTrulieve Cannabis Corp. | B | C | A | $8.41 |
| CRONCronos Group Inc. Common Share | C | B | B | $2.75 |
| GLASGlass House Brands Inc. | C | C | B | $10.34 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $4.35 |
| USNAUSANA Health Sciences Inc | B | D | C | $22.65 |
| CGCCanopy Growth Corporation Common Shares | B | C | C | $0.93 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.40 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.29 |
About
Natural Alternatives International is a nutritional supplement and healthcare product manufacturer serving U.S. and international markets through contract manufacturing and licensing. Its Private-Label Contract Manufacturing segment, the primary revenue driver, manufactures supplements and healthcare products for third-party distributors. The company also generates royalty income through patent and trademark licensing agreements.